Positive troponin T without cardiac involvement in inclusion body myositis

被引:17
作者
Schwarzmeier, JD
Hamwi, A
Preisel, M
Resl, C
Preusser, M
Sluga, E
Horcher, E
Shehata, MM
机构
[1] Med Univ Vienna, Dept Hematol, A-1097 Vienna, Austria
[2] Med Univ Vienna, Boltzmann Inst Cytokine Res, A-1097 Vienna, Austria
[3] Med Univ Vienna, Inst Lab Diag, A-1097 Vienna, Austria
[4] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria
[5] Med Univ Vienna, Dept Surg, A-1097 Vienna, Austria
[6] Rudolfinerhaus Hosp, A-1190 Vienna, Austria
关键词
cTnT; cTnI; myopathies; myocardial infarction; differential diagnosis;
D O I
10.1016/j.humpath.2005.06.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cardiac troponin T (cTnT) is considered as a specific marker for acute myocardial infarction. Here, we present a case with elevated cTnT, determined by a third-generation assay, without signs of a myocardial lesion. Routine investigation of a 66-year-old female patient with indolent B-cell lymphoma revealed increased serum levels of creatine kinase (CK), MB fraction of CK (CK-MB), and cTnT, although she did not complain of cardiac symptoms. Electrocardiographic monitoring, echocardiography, magnetic resonance computed angiography, and percutaneous coronary angiography excluded myocardial damage. However, the close follow-up showed a steady increase of CK-MB and cTnT levels and gradual development of weakness in both thighs. A biopsy of the right quadriceps muscle led to the diagnosis of inclusion body myositis. In contrast to cTnT, cardiac troponin I could not be detected retrospectively in any of her serum samples. These results demonstrate for the first time that cTnT is elevated in patients with inclusion body myositis. (c) 2005 Published by Elsevier Inc.
引用
收藏
页码:917 / 921
页数:5
相关论文
共 25 条
  • [1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Alto, P
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    Van de Werf, F
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 959 - 969
  • [2] Inclusion body myositis
    Richard J. Barohn
    Anthony A. Amato
    [J]. Current Treatment Options in Neurology, 2000, 2 (1) : 7 - 11
  • [3] Bodor GS, 1997, CLIN CHEM, V43, P476
  • [4] BODOR GS, 1995, CLIN CHEM, V41, P1710
  • [5] Inclusion body myositis in connective tissue disorders: case report and review of the literature
    Derk, CT
    Vivino, FB
    Kenyon, L
    Mandel, S
    [J]. CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) : 324 - 328
  • [6] Cardiac troponin and β-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis
    Erlacher, P
    Lercher, A
    Falkensammer, J
    Nassonov, EL
    Samsonov, MI
    Shtutman, VZ
    Puschendorf, B
    Mair, J
    [J]. CLINICA CHIMICA ACTA, 2001, 306 (1-2) : 27 - 33
  • [7] THE TROPONIN COMPLEX AND REGULATION OF MUSCLE-CONTRACTION
    FARAH, CS
    REINACH, FC
    [J]. FASEB JOURNAL, 1995, 9 (09) : 755 - 767
  • [8] Gaze DC, 2001, CLIN CHEM, V47, pA201
  • [9] INCLUSION-BODY MYOSITIS AND MYOPATHIES
    GRIGGS, RC
    ASKANAS, V
    DIMAURO, S
    ENGEL, A
    KARPATI, G
    MENDELL, JR
    ROWLAND, LP
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (05) : 705 - 713
  • [10] Hammerer-Lercher A, 2001, CLIN CHEM, V47, P451